Could COVID-19 infections trigger a relapse of mycosis fungoides or other cutaneous T-cell lymphomas?
Recently, authors highlighted the potential role of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in triggering the relapse of mycosis fungoides, a type of cutaneous T-cell lymphoma.